0.35 +0.01 (2.70%)
CYTR
| Trade CYTR now with |
|
Stock Details
Last Trade:0.35 Change:+0.01 (2.70%) Prev Close:0.34 Open: 0.37 Days Range:0.32 – 0.37 52 Week Range: 0.24 - 1.06 Volume:2526174 P/E: N/AEPS:-0.04
View AllRecent Alerts 02/09/12
Recent Alert on 12/22/11 at 8:39am
CytRx (CYTR) Initiates Dxorubicin Conjugate INNO-206 Phase 2b
CytRx (CYTR) Initiates Dxorubicin Conjugate INNO-206 Phase 2b
CytRx Corporation (Nasdaq: CYTR) has announced the initiation of an international Phase 2b clinical trial to evaluate the preliminary efficacy and safety of its tumor-targeting doxorubicin conjugate INNO-206 in patients with late-stage soft tissue... Read More
Recent Alert on 12/12/11 at 8:31am
CytRx (CYTR) Reports Favorable Phase 2 ENABLE in Certain B-CLL Patients
CytRx (CYTR) Reports Favorable Phase 2 ENABLE in Certain B-CLL Patients
Recent Alert on 12/12/11 at 8:31am
CytRx (CYTR) Reports Favorable Phase 2 ENABLE in Certain B-CLL Patients
CytRx (CYTR) Reports Favorable Phase 2 ENABLE in Certain B-CLL Patients
View AllRecent Press Releases
View AllRecent SEC Filings
No Recent SEC Filings Available